Artiklar med krav på offentlig åtkomst - Roslyn FrancisLäs mer
Inte tillgängliga någonstans: 6
[177Lu] Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
MS Hofman, L Emmett, S Sandhu, A Iravani, AM Joshua, JC Goh, ...
The Lancet 397 (10276), 797-804, 2021
Krav: National Health and Medical Research Council, Australia
Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group
AK Nowak, SG Armato III, GL Ceresoli, H Yildirim, RJ Francis
Lung cancer 70 (1), 1-6, 2010
Krav: US National Institutes of Health
Semiautomatic volume of interest drawing for 18F-FDG image analysis—method and preliminary results
AJ Green, RJ Francis, S Baig, RHJ Begent
European journal of nuclear medicine and molecular imaging 35, 393-406, 2008
Krav: Cancer Research UK
ENZA‐p trial protocol: a randomized phase II trial using prostate‐specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration …
L Emmett, S Subramaniam, AM Joshua, M Crumbaker, A Martin, ...
BJU international 128 (5), 642-651, 2021
Krav: National Health and Medical Research Council, Australia, Medical Research …
The effect of Vitamin-K1 and Colchicine on Vascular Calcification Activity in subjects with Diabetes Mellitus (ViKCoVaC): A double-blind 2x2 factorial randomized controlled trial
JW Bellinge, RJ Francis, SC Lee, A Vickery, W Macdonald, SK Gan, ...
Journal of Nuclear Cardiology 29 (4), 1855-1866, 2022
Krav: National Health and Medical Research Council, Australia
Overall survival and quality of life with [177Lu] Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary …
L Emmett, S Subramaniam, M Crumbaker, AM Joshua, S Sandhu, ...
The Lancet Oncology, 2025
Krav: National Health and Medical Research Council, Australia
Tillgängliga någonstans: 28
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu] Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP …
JP Buteau, AJ Martin, L Emmett, A Iravani, S Sandhu, AM Joshua, ...
The Lancet Oncology 23 (11), 1389-1397, 2022
Krav: US Department of Defense, National Health and Medical Research Council …
TheraP: a randomized phase 2 trial of 177Lu‐PSMA‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer …
MS Hofman, L Emmett, J Violet, A Y. Zhang, NJ Lawrence, M Stockler, ...
BJU international 124, 5-13, 2019
Krav: National Health and Medical Research Council, Australia
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
AK Nowak, AM Cook, AM McDonnell, MJ Millward, J Creaney, RJ Francis, ...
Annals of Oncology 26 (12), 2483-2490, 2015
Krav: National Health and Medical Research Council, Australia
Interventional therapies for malignant pleural effusions: the present and the future
R Thomas, R Francis, HE Davies, YCG Lee
Respirology 19 (6), 809-822, 2014
Krav: National Health and Medical Research Council, Australia
Is prostate-specific membrane antigen positron emission tomography/computed tomography imaging cost-effective in prostate cancer: an analysis informed by the proPSMA trial
RE de Feria Cardet, MS Hofman, T Segard, J Yim, S Williams, RJ Francis, ...
European urology 79 (3), 413-418, 2021
Krav: US Department of Defense
Overall survival with [177Lu] Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase …
MS Hofman, L Emmett, S Sandhu, A Iravani, JP Buteau, AM Joshua, ...
The Lancet Oncology 25 (1), 99-107, 2024
Krav: National Health and Medical Research Council, Australia, Medical Research …
Synthesis of human amyloid restricted to liver results in an Alzheimer disease–like neurodegenerative phenotype
V Lam, R Takechi, MJ Hackett, R Francis, M Bynevelt, LM Celliers, ...
PLoS biology 19 (9), e3001358, 2021
Krav: National Health and Medical Research Council, Australia
UpFrontPSMA: a randomized phase 2 study of sequential 177Lu‐PSMA‐617 and docetaxel vs docetaxel in metastatic hormone‐naïve prostate cancer (clinical trial …
N Dhiantravan, L Emmett, AM Joshua, DA Pattison, RJ Francis, S Williams, ...
BJU international 128 (3), 331-342, 2021
Krav: US Department of Defense, National Health and Medical Research Council …
Accuracy of dose calibrators for 68Ga PET imaging: unexpected findings in a multicenter clinical pretrial assessment
DL Bailey, MS Hofman, NJ Forwood, GJ O’Keefe, AM Scott, ...
Journal of Nuclear Medicine 59 (4), 636-638, 2018
Krav: National Health and Medical Research Council, Australia
A phase I clinical trial of CHT-25 a 131I-labeled chimeric anti-CD25 antibody showing efficacy in patients with refractory lymphoma
G Dancey, J Violet, A Malaroda, AJ Green, SK Sharma, R Francis, ...
Clinical Cancer Research 15 (24), 7701-7710, 2009
Krav: Cancer Research UK
Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world
CB Hirschfeld, LJ Shaw, MC Williams, R Lahey, TC Villines, S Dorbala, ...
Cardiovascular Imaging 14 (9), 1787-1799, 2021
Krav: US National Institutes of Health, American Heart Association
Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group
SG Armato III, RJ Francis, SI Katz, G Ak, I Opitz, E Gudmundsson, ...
Lung Cancer 130, 108-114, 2019
Krav: US National Institutes of Health, Cancer Research UK, Chief Scientist Office …
Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome
K Majeed, JW Bellinge, SC Butcher, R Alcock, J Spiro, D Playford, ...
Atherosclerosis 319, 142-148, 2021
Krav: British Heart Foundation
The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial
JW Bellinge, RJ Francis, SC Lee, NP Bondonno, M Sim, JR Lewis, ...
The American Journal of Clinical Nutrition 115 (1), 45-52, 2022
Krav: Wellcome Trust
Publikations- och finansieringsuppgifter tas fram automatiskt av ett datorprogram.